Skip to main content

Table 2 Disease course of monofocal vs. multifocal placebo patients after the CIS

From: MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome

  All Monofocal Multifocal p-value*
N 176 93 83  
CDMS %* over 2 years 45% 47% 44% 0.7052
Median annualized cumulative number of NALs over the study (quartiles) 3.2
(0.96–10.4)
3.0
(0.5–9.4)
3.6
(1.0–12.5)
0.4698
  1. *Compares monofocal vs. multifocal patients
  2. NAL: newly active lesion
  3. CDMS: clinically definite MS
  4. Kaplan-Meier estimate at day 720, Log rank test
  5. Wilcoxon test